RxDoctor Payments Data

James Keeney, MD

Adult Reconstructive Orthopaedic Surgery · Columbia, MONPI 1104833540

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,195 of the $22,099 with a category attached, or 77.8%. Medical Device Business Services, Inc. accounts for 85.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $17,185 and has fallen 99.3% since, to $120 in 2025.

$22,099in general payments, 2019–2025

Across 47 payments — averaging $470.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$19K
  • Heron Therapeutics, Inc.$2K
  • Johnson & Johnson$755
  • Zimmer Biomet$211
  • Heraeus Medical, LLC.$48
  • Stryker$27
  • plus $38 from 2 others
$80,799in research payments, 2019–2025

Across 14 payments — averaging $5771.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • KCI USA, Inc.$67K
  • Medical Device Business Services, Inc.$14K

What the payments were for

  • Consulting fees$17,19578%
  • Speaking & faculty fees$6003%
  • Travel & lodging$2,80313%
  • Food & beverage$1,5017%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,099 in reported general payments places this provider in the 65th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.

See all adult reconstructive orthopaedic surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$161,016
Medicare patients
308
Services billed
504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin63$264
Gabapentin12$154
Meloxicam41$114
Cyclobenzaprine Hcl20$89
Tramadol Hcl12$41
Clindamycin Hcl19$17

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →